T
Tizona Therapeutics
tizonatx.comHeadquarters
United States
Valuation
$601M
Total Funding
$370M
Investors
Gilead Sciences
Description
Tizona Therapeutics is developing cancer treatments that have the potential to be first- and best-in-class treatments, and core components of immunotherapy combination regimens.